Evidence map›Paper›PMID 32788424›Full record

ArticleAging2020

COVID-19 mortality in Lombardy: the vulnerability of the oldest old and the resilience of male centenarians.

Gabriella Marcon, Mauro Tettamanti, Giorgia Capacci, Giulia Fontanel, Marco Spanò, Alessandro Nobili, Gianluigi Forloni, Claudio Franceschi

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. The long-lived immune system of centenarians.Nature reviews. Immunology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Centenarians born before 1919 are resistant to COVID-19.Aging clinical and experimental research · 2023
    Article
  15. Article
  16. Centenarians From Long-Term Care Facilities and COVID-19-Relevant Hospital Admissions.Journal of the American Medical Directors Association · 2022
    Article
  17. Article
  18. Immunosenescence and COVID-19.Mechanisms of ageing and development · 2022
    Review
  19. Article
  20. Immunosenescence, aging and successful aging.Frontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Gabriella MarconDAME, University of Udine, Udine, Italy.
Mauro TettamantiDepartment of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Giorgia CapacciDirectorate for Social Statistics and Population Census, Istat, Italy.
Giulia FontanelDepartment of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Marco SpanòAzienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), Trieste, Italy.
Alessandro NobiliDepartment of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Gianluigi ForloniDepartment of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Claudio FranceschiDepartment of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Mario Negri Institute for Pharmacological Research · ITAzienda Sanitaria Universitaria Integrata di Trieste · ITNational Institute of Statistics · ITN. I. Lobachevsky State University of Nizhny Novgorod · RUUniversity of Trieste · ITUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Italy was the first European nation to be affected by COVID-19. The biggest cluster of cases occurred in Lombardy, the most populous Italian region, and elderly men were the population hit in the hardest way. Besides its high infectivity, COVID-19 causes a severe cytokine storm and old people, especially those with comorbidities, appear to be the most vulnerable, presumably in connection to inflammaging. In centenarians inflammaging is much lower than predicted by their chronological age and females, presenting survival advantage in almost all centenarian populations, outnumber males, a phenomenon particularly evident in Northern Italy. Within this scenario, we wondered if: a) the COVID-19 mortality in centenarians was lower than that in people aged between 50 and 80 and b) the mortality from COVID-19 in nonagenarians and centenarians highlighted gender differences.We checked COVID-19-related vulnerability/mortality at the peak of infection (March 2020), using data on total deaths (i.e. not only confirmed COVID-19 cases). Our conclusion is that excess mortality increases steadily up to very old ages and at the same time men older than 90 years become relatively more resilient than age-matched females.

Indexed as

AgingCoronavirus InfectionsInflammationMortalityPandemicsPneumonia, ViralAgedAged, 80 and overAge FactorsBetacoronavirusCOVID-19FemaleHealth Services for the AgedHealth Services Needs and DemandHealth Status DisparitiesHumanscentenariansCOVID-19inflammagingmortalityoldest-old

Identifiers

PMID32788424
PMCPMC7467374
OpenAlexW3048388221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.